Antidral

Poland
Brand name Antidral
Form solution for skin
Active substance / Dosage
Aluminum chloride · 100 mg/1 g
Prescription type Over-the-counter
ATC code
Registration number 100006028
Manufacturer Nobilus Ent
Antidral solution for skin

PACKAGE LEAFLET: INFORMATION FOR THE USER

ANTIDRAL 100 mg/g, cutaneous solution
(Aluminium chloride)
Please read all of this leaflet carefully before using this medicine, because it contains
important information for the patient.
This medicine should always be used exactly as described in this patient leaflet or as directed by
a doctor or pharmacist.

  • Keep this leaflet so that you can read it again if necessary.
  • If you need advice or further information, consult your pharmacist.
  • If you experience any adverse reactions, including any not listed in this leaflet, inform your doctor or pharmacist. See section 4.
  • If symptoms do not improve or worsen, consult your doctor.

Leaflet contents:

  1. What Antidral is and what it is used for
  2. What you need to know before using Antidral
  3. How to use Antidral
  4. Possible side effects
  5. How to store Antidral
  6. Contents of the pack and other information

1. WHAT ANTIDRAL IS AND WHAT IT IS USED FOR

Antidral contains aluminium chloride, which reduces the activity of sweat glands by denaturing
proteins within the glands and binding to fibrin fibres forming the endings of exocrine glands.
After application, internal pressure within the sweat duct increases (a feedback mechanism),
resulting in inhibition of sweat secretion from the sweat glands. Other components of the medicine
facilitate absorption of the active substance and significantly reduce the risk of superficial skin infections.
Antidral is applied topically to skin areas affected by excessive sweating, such as feet, armpits, and hands.
Antidral eliminates or alleviates unpleasant symptoms associated with excessive sweating.

2. IMPORTANT INFORMATION BEFORE USING THE MEDICINAL PRODUCT ANTIDRAL

When not to use Antidral

  • If the patient has a known allergy (hypersensitivity) to the active substance or to any of the other components of the medicine;
  • The solution should not be used in case of damaged skin, or after shaving or depilation.

Warnings and precautions
The use of the medicine should be limited only to those areas of the skin for which the solution is indicated.
Contact of Antidral solution with mucous membranes and eyes should be avoided.

  • Do not wash the skin immediately before applying the medicine. If the solution is applied to the underarm area, these areas should not be shaved within 12 hours before or after application, due to the risk of skin reactions.
  • Antidral may damage or decolorize clothing.
  • The product is flammable. Do not use near open flames, lit cigarettes, or certain devices (e.g. hair dryers).

Other medicines and Antidral
No data available.
Inform your doctor about all medicines you have recently taken, including those available without a prescription.
Antidral with food and drink
Not applicable.
Children
There is no data on the use of the solution in children.
Consult a doctor before using the medicine.
Patients with renal impairment
Not applicable.
Pregnancy and breastfeeding
Before using any medicine, consult a doctor or pharmacist.
Driving and operating machinery
Antidral has no effect on the ability to drive or operate machinery.
Important information about certain ingredients of Antidral
Antidral contains ethanol (96%).
This medicine contains 500 mg of alcohol (ethanol) in each gram of solution.
Antidral may cause a burning sensation on damaged skin.
In neonates (preterm infants and full-term newborns), high concentrations of ethanol may cause severe local and systemic toxicity due to significant absorption through immature skin (especially under occlusive dressing).

3. HOW TO USE ANTIDRAL

The liquid is for external use only.
Antidral should be applied every night (when sweat gland activity is lower), after thoroughly washing and drying the skin (avoid rubbing). In cases of less intense sweating, it is recommended to use the liquid every second or third day, depending on individual patient needs.
This medicine should always be used according to the instructions in the patient leaflet. If in doubt, consult a doctor or pharmacist.
Use of a higher than recommended dose of Antidral
Overdose may cause skin irritation. If skin irritation occurs, discontinue use of Antidral. Apply a mild cream containing hydrocortisone to the irritated areas. Antidral may be used again after complete resolution of irritation symptoms.
Overdose is treated symptomatically.
If there are any further doubts regarding the use of this medicine, consult a doctor or pharmacist.

4. POSSIBLE ADVERSE REACTIONS

Like all medicines, this medicine can cause adverse reactions, although not everyone will experience them.
During use of the solution, skin irritation symptoms such as burning, itching, or redness may occur.
If this happens, treatment should be discontinued.
In some individuals, other adverse reactions may occur during use of Antidral solution.
If any other adverse effects not listed in this leaflet occur, inform your doctor.

Reporting of adverse reactions
If any adverse reactions occur, including any adverse reactions not listed in this leaflet, inform your doctor, pharmacist, or nurse. Adverse reactions can be reported directly to the Department of Monitoring of Adverse Drug Reactions of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Adverse reactions can also be reported to the marketing authorization holder.
By reporting adverse reactions, more information on the safety of this medicine can be collected.

5. HOW TO STORE ANTIDRAL

Store below 25°C.
Keep in a place invisible and inaccessible to children.
Store in an upright position in a tightly closed container.
Do not use this medicine after the expiry date stated on the bottle and carton. The expiry date refers to the last day of the stated month.
Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. Such practices help protect the environment.

6. CONTENTS OF THE PACKAGE AND OTHER INFORMATION

What Antidral contains
The active substance is aluminium chloride (1 gram of solution contains 100 mg of aluminium chloride).
The other ingredients are: glycerol, ethanol, purified water, hydroxyethylcellulose.
What Antidral looks like and contents of the pack
A bottle made of high-density polyethylene (HDPE), with a GGNX-18-D003 type polyethylene collar, ball, and grey polypropylene cap, packed in a cardboard box.
1 bottle contains 50 ml of solution.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Teva Pharmaceuticals Polska Sp. z o.o.
Emilii Plater 53 Street
00-113 Warsaw
Tel: (22) 345 93 00
Manufacturer
Nobilus Ent
Zegrzyńska 22A Street
05-110 Jabłonna
Poland